Publisher
Springer Science and Business Media LLC
Subject
Condensed Matter Physics,General Materials Science,Biochemistry,General Chemistry
Reference69 articles.
1. W. Zhang, G.-J. Yang, S.-X. Wu, D.-Q. Li, Y.-B. Xu, C.-H. Ma, J.-L. Wang, and W.-W. Chen (2018). The guiding role of bone metabolism test in osteoporosis treatment. Am. J. Clin. Exp. Immunol. 7, 40.
2. G. Adami, K. G. Saag, A. S. Mudano, E. J. Rahn, N. C. Wright, R. C. Outman, S. L. Greenspan, A. Z. LaCroix, J. W. Nieves, and S. L. Silverman (2020). Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment. Osteoporos. Int. 31, 1283–1290.
3. C.-H. Wu, Y.-F. Chang, C.-H. Chen, E. M. Lewiecki, C. Wüster, I. Reid, K.-S. Tsai, T. Matsumoto, L. B. Mercado-Asis, and D.-C. Chan (2019). Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region. J. Clin. Densitom. 24, 3.
4. S. P. Schiellerup, K. Skov-Jeppesen, J. A. Windeløv, M. S. Svane, J. J. Holst, B. Hartmann, and M. M. Rosenkilde (2019). Gut hormones and their effect on bone metabolism. Potential drug therapies in future osteoporosis treatment. Front. Endocrinol. (Lausanne) 10, 75.
5. K. Ebina, M. Hirao, H. Tsuboi, Y. Nagayama, M. Kashii, S. Kaneshiro, A. Miyama, H. Nakaya, Y. Kunugiza, and G. Okamura (2020). Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis. Bone 140, 115574.